Arun Upadhyay - Jan 2, 2024 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Scientific Officer, Head of Research, Development and Medical
Signature
/s/ Arun Upadhyay
Stock symbol
OCGN
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 05:04 PM
Previous filing
Sep 19, 2023
Next filing
Jan 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +138K $0.00 138K Jan 2, 2024 Common Stock 138K $0.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on January 2, 2025, subject to continued service with the Issuer on the applicable vesting dates.

Remarks:

Chief Scientific Officer, Head of Research, Development and Medical